TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: immediate improvement rate of irritative cough
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cough score reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of CBD cannulation within 6 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Overall frequency of CBD cannulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: tolerance of tourniquet
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to first postoperative analgesic request
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incremental diagnostic value of integrated PET-CT imaging
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incremental impact on management
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: weaning success rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of POCTs for influenza
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of POCTs for influenza
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost-effectiveness of PCR
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Neurologic impairment score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Barthel Index (BI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Shoulder range of motion (ROM)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of shoulder joint contracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time to achieve a stone-free state
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: UW-mRS values for mRS categories 0-6
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of SVM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of SVM
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: death or dependency at 90 days
Endpoint domain: Mortality/survival
Primary endpoint: ECP levels in the serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: analgesia potency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: success rate of vein closure
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: estimated GFR loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: mean anxiety level
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: mean satisfaction score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Endometrial hyperplasia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: student satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ARDS rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Need for delivery room resuscitation
Endpoint domain: Adverse events/effects
Primary endpoint: Energy/Fatigue scores
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Pain scores during movement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: blood glucose levels during OGTT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Increase in high-density lipoprotein cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Decrease in triacylglycerols
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Decrease in high-sensitive C-reactive protein
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: ATRS score at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heel-rise work test results
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Severity of postoperative nausea and vomiting (PONV)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative haemoglobin values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: seric ox-LDL concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 12-step meeting attendance
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: engagement in related activities
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Need for ureteroscopy
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Prenatal attachment levels
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: ALRI hospitalizations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of parents asked about smoking
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of chromium and nickel in urine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area under the curve (AUC) for platelet aggregometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Platelet reactivity units (PRU)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Agreement for organism identification
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Antibiotic error rates
Endpoint domain: Adverse events/effects
Primary endpoint: Adverse reactions during and following anesthesia
Endpoint domain: Adverse events/effects
Primary endpoint: Opposition to attend a subsequent dental appointment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Adverse effects of misoprostol
Endpoint domain: Adverse events/effects
Primary endpoint: Concentrations of dolutegravir and darunavir
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: No grade 3 or 4 adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: 24-h average pain ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Isc-CFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of postoperative pruritus
Endpoint domain: Adverse events/effects
Primary endpoint: Grade 3 RTOG toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: Grade 3 CTCAE toxicity
Endpoint domain: Adverse events/effects
Primary endpoint: CSF total and ionized Mg concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in weekly mean 24-h average pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement on CGI-S
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement on SF-36
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: tacrolimus C(0) concentration on day 3
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall daily tacrolimus dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of early BPAR
Endpoint domain: Adverse events/effects
Primary endpoint: Sensitivity of NIRS in detecting hematomas
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Erythema Index (EI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lesion counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physician Global Assessment (PGA) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: children's healthy food intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: parental self-efficacy regarding regulation of children's eating behaviours
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in dietary habits
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: percentage reduction of corneal epithelial defect size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CSS evolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HAQ progression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cumulative percent dose of 13C recovery per 6 h (cPDR/6 h)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: maximal PDR (PDR(peak))
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Average increase in GBMD-value
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ghrelin/PYY ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postprandial ghrelin levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Morning blood pressure (BP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time to resumption of normal activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Attitude towards smoking
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Objective Response (OR) rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Suicidal Ideation (SI) prevalence
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of patients re-hospitalized due to all causes
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Proportion of patients re-hospitalized for surgical intervention
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Length of re-hospitalization
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: reduction of bulimic symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: plasma alpha-tocopherol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: LDL susceptibility to oxidation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: early postoperative incidence of nausea
Endpoint domain: Adverse events/effects
Primary endpoint: early postoperative incidence of vomiting
Endpoint domain: Adverse events/effects
Primary endpoint: intraop consumption of opioid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: National Institutes of Health Chronic Prostatitis Symptom Index scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: International Index of Erectile Function‐5 scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Self‐Rating Anxiety Scale scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Accuracy of pain-related ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global health status/QOL scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Scores of worrying about the future
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: overall tolerance grading
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of daily incontinence episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average void volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of life (IIQ total score)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: complete pain relief at 30 min
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean pre‐elective and post‐elective scores
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: VAS values for postoperative pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Provision of written short-term asthma management plans
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lumen diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Birth preparedness score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Prevalence of normoglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Muscular strength improvements
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median days to ethics and regulatory approval
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Airway responsiveness (PC20 methacholine)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: VE volume before CO2 loading
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Reduction in plasma concentration of apo-B lipoproteins
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in VLDL-cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: treatment failure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Additional steps per day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Additional MVPA in bouts (minutes per week)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality-adjusted life-years (QALYs) gained
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Absorption of subretinal fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 3-month recurrence rate
Endpoint domain: Mortality/survival
Primary endpoint: in situ recurrence rate
Endpoint domain: Mortality/survival
Primary endpoint: CD4 counts 24 weeks postpartum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Contents of cysteine (Cys), Hcy, s‐adenosylmethionine (SAM), and SAH
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Contents of methionine (Met), glutathione (GSH), and Cys‐gly
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Panic rate after CCK-4 challenge
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: peak ocular pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fasting plasma total cholesterol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Fasting plasma LDL-cholesterol concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Postprandial lipemia (24-h area under the plasma triacylglycerol curve)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Documentation of ENA criteria
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cardiac energetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Consultation time
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Consultation costs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: PEQ domain scores for Communications, Emotions and Barriers
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Puncture time
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: One-time puncture success rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Postprandial increase in HVPG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: sprint speeds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: first-drive power
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: passing accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: opioid requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Completion of Advance Directives (ADs)
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Appointment of surrogate decision-makers
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Quality of life in pupils with headache
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Prevalence of headache on ≥15 days/month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Days of school lost due to headache
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Improvement in angina class
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mastodynia symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in hip adduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Decrease in trunk flexion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Decrease in gluteus medius activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: side effect ratings
Endpoint domain: Adverse events/effects
Primary endpoint: median SNAP amplitude
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction in hypnotic and sedative drug use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean drug costs per recurrence-free life month (RFLM)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: mean medical costs per recurrence-free life month (RFLM)
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: vocal cord visualization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Fatigue Severity Scores
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Plasma cortisol levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: lower-extremity muscle strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: feasibility of the program
Endpoint domain: Life impact
Endpoint subdomain: null
Primary endpoint: Mean blood velocity of the superior mesenteric artery (SMA‐Vmean)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Portal blood flow (PBF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Total hepatic blood flow (HBF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: BDI score indicating moderate to severe depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total insulin consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Lipid profile (total cholesterol, triglycerides, LDL-cholesterol, HDL-cholesterol)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean discomfort score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Rate of absorption of salicylate from enteric-coated tablets
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MACE rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for repeat revascularization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Normalization of urine specimens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Mean pain score after injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cognitive functioning (MMSE score)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: PC20FEV1 level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Quality of midwife examination satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Left Ventricular End Systolic Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Interleukin-2 responses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: mean ASSET
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Heart rate response during Valsalva maneuver
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Probability of needing a platelet transfusion
Endpoint domain: Adverse events/effects
Primary endpoint: lower eyelid retraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes